Stay updated on Prophylactic Emicizumab in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.

Latest updates to the Prophylactic Emicizumab in Hemophilia A Clinical Trial page
- Check6 days agoChange DetectedAdded 'Hereditary factor VIII deficiency disease' as a related disease term and included a link to the Genetic and Rare Diseases Information Center (GRDR) for further information.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision: v3.5.0 added; Hemophilia A and the Genetic and Rare Diseases Information Center resource were removed (previous revision v3.4.3 also removed).SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision: v3.4.2 was added to the page and the funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedNotice: A government-funding lapse notice with open NIH Clinical Center status and a revision to v3.4.1 were added, and the reference to v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedThe changes are minor UI and metadata updates (glossary toggle, capitalization adjustments to QC criteria labels, and a new version label) that do not affect study content or core page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Prophylactic Emicizumab in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.